{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T10:00:14Z","timestamp":1780653614423,"version":"3.54.1"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Prostate cancer (PCa) is among the most common malignancies worldwide, with Black men experiencing significantly higher incidence, earlier onset, and more aggressive disease. These disparities reflect a complex interplay of factors. Adiposity, particularly visceral and periprostatic adipose tissue (PPAT), has emerged as a potential contributor to PCa progression, though its role in modifying racial disparities remains unclear. We conducted a narrative review to evaluate the relationship between obesity, visceral adiposity, PPAT, and PCa risk and aggressiveness, with attention to racial differences. A directed acyclic graph was developed to illustrate hypothesized pathways. Strong evidence supports associations between obesity, visceral fat, and aggressive PCa. Black men tend to have lower visceral and PPAT volumes than White men. However, these depots may exert greater biological effects in Black men, possibly due to differences in inflammatory signaling or fat composition. PPAT and waist-hip ratio may amplify aggressive PCa features in Black men while downplaying them in non-Black men. Adiposity may serve as a biomarker and modifier of racial disparities in PCa. An improved study design is needed to clarify mechanisms and inform targeted interventions. Understanding these interactions is essential to reducing PCa disparities in high-risk populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cej.0000000000000992","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:24:07Z","timestamp":1761056647000},"page":"362-369","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The intersection of race and adiposity in prostate cancer: a narrative review"],"prefix":"10.1097","volume":"35","author":[{"given":"Matthew","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Lawen","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka S.","family":"Garcia","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeissen","family":"Pyo","sequence":"additional","affiliation":[{"name":"McGovern Medical School, The University of Texas Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hahn","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Genitourinary Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Frigo","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of Genitourinary Medical Oncology"},{"name":"Division of Diagnostic Imaging, Department of Cancer Systems Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Cancer Medicine, Department of General Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wei","sequence":"additional","affiliation":[{"name":"Division of Discovery Science, Department of Biostatistics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Robert","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention and Population Sciences, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisly","family":"Chery","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian F.","family":"Chapin","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie R.","family":"Daniel","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention and Population Sciences, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Pettaway","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin R.","family":"Gregg","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"R1-20260605","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","article-title":"Obesity and prostate cancer: weighing the evidence.","volume":"63","author":"Allott","year":"2013","journal-title":"Eur Urol"},{"key":"R2-20260605","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1158\/1055-9965.EPI-14-0236","article-title":"Racial differences in adipose tissue distribution and risk of aggressive prostate cancer among men undergoing radiation therapy.","volume":"23","author":"Allott","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R3-20260605","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12916-022-02457-3","article-title":"The lipidomic profile of the tumoral periprostatic adipose tissue reveals alterations in tumor cell\u2019s metabolic crosstalk.","volume":"20","author":"Altuna-Coy","year":"2022","journal-title":"BMC Med"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.3390\/ijms22115560","article-title":"Emerging roles for browning of white adipose tissue in prostate cancer malignant behaviour.","volume":"22","author":"\u00c1lvarez-Artime","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R5-20260605","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12964-023-01294-y","article-title":"Castration promotes the browning of the prostate tumor microenvironment.","volume":"21","author":"Alvarez-Artime","year":"2023","journal-title":"Cell Commun Signal"},{"key":"R6-20260605","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.ejca.2015.07.042","article-title":"High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting.","volume":"51","author":"Antoun","year":"2015","journal-title":"Eur J Cancer"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/jamaoncol.2015.0513","article-title":"Difference in association of obesity with prostate cancer risk between US African American and non-Hispanic white men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).","volume":"1","author":"Barrington","year":"2015","journal-title":"JAMA Oncol"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/cncr.22461","article-title":"Features of the metabolic syndrome and prostate cancer in African-American men.","volume":"109","author":"Beebe-Dimmer","year":"2007","journal-title":"Cancer"},{"key":"R9-20260605","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.urology.2009.03.013","article-title":"Racial differences in risk of prostate cancer associated with metabolic syndrome.","volume":"74","author":"Beebe-Dimmer","year":"2009","journal-title":"Urology"},{"key":"R10-20260605","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1207\/s15327655jchn1203_4","article-title":"Prostate cancer in African American men: increasing knowledge and self-efficacy.","volume":"12","author":"Boehm","year":"1995","journal-title":"J Community Health Nurs"},{"key":"R11-20260605","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41568-020-0267-9","article-title":"Prostate carcinogenesis: inflammatory storms.","volume":"20","author":"de Bono","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"R12-20260605","doi-asserted-by":"crossref","first-page":"204","DOI":"10.7150\/jca.89750","article-title":"Periprostatic adipose tissue: a new perspective for diagnosing and treating prostate cancer.","volume":"15","author":"Cao","year":"2024","journal-title":"J Cancer"},{"key":"R13-20260605","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.6004\/jnccn.2015.0181","article-title":"NCCN clinical practice guidelines prostate cancer early detection, version 2. 2015.","volume":"13","author":"Carroll","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"R14-20260605","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/cncr.23695","article-title":"Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.","volume":"113","author":"Chamie","year":"2008","journal-title":"Cancer"},{"key":"R15-20260605","doi-asserted-by":"crossref","first-page":"djx084","DOI":"10.1093\/jnci\/djx084","article-title":"Two novel susceptibility loci for prostate cancer in men of African ancestry.","volume":"109","author":"Conti","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"R16-20260605","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIR.0b013e318233bc6a","article-title":"Assessing adiposity: a scientific statement from the American Heart Association.","volume":"124","author":"Cornier","year":"2011","journal-title":"Circulation"},{"key":"R17-20260605","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1056\/NEJMra2032804","article-title":"Reassessing human adipose tissue.","volume":"386","author":"Cypess","year":"2022","journal-title":"N Engl J Med"},{"key":"R18-20260605","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1038\/s41598-017-04951-8","article-title":"Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease.","volume":"7","author":"Dahran","year":"2017","journal-title":"Sci Rep"},{"key":"R19-20260605","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1002\/cncr.32167","article-title":"Body fat distribution on CT imaging and prostate cancer risk and mortality in the AGES-Reykjavik Study.","volume":"125","author":"Dickerman","year":"2019","journal-title":"Cancer"},{"key":"R20-20260605","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/cancers17030372","article-title":"Periprostatic adipose tissue as a contributor to prostate cancer pathogenesis: a narrative review.","volume":"17","author":"Drewa","year":"2025","journal-title":"Cancers"},{"key":"R21-20260605","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.3390\/cancers15174284","article-title":"Racial\/ethnic disparities in prostate cancer 5-year survival: the role of health-care access and disease severity.","volume":"15","author":"El Khoury","year":"2023","journal-title":"Cancers"},{"key":"R22-20260605","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.3390\/cancers16173023","article-title":"The interplay between structural inequality, allostatic load, inflammation, and cancer in Black Americans: a narrative review.","volume":"16","author":"Esdaille","year":"2024","journal-title":"Cancers"},{"key":"R23-20260605","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2337\/dc12-0336","article-title":"Metabolic syndrome and risk of cancer: a systematic review and meta-analysis.","volume":"35","author":"Esposito","year":"2012","journal-title":"Diabetes Care"},{"key":"R24-20260605","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/ijc.31553","article-title":"Quantitative association between body mass index and the risk of cancer: a global Meta-analysis of prospective cohort studies.","volume":"143","author":"Fang","year":"2018","journal-title":"Int J Cancer"},{"key":"R25-20260605","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejca.2017.12.017","article-title":"Fatty acid profile in peri-prostatic adipose tissue and prostate cancer aggressiveness in African-Caribbean and Caucasian patients.","volume":"91","author":"Figiel","year":"2018","journal-title":"Eur J Cancer"},{"key":"R26-20260605","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/jcm8020201","article-title":"Obesity, inflammation, and prostate cancer.","volume":"8","author":"Fujita","year":"2019","journal-title":"J Clin Med"},{"key":"R27-20260605","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/pcan.2017.1","article-title":"Meta-analysis of metabolic syndrome and prostate cancer.","volume":"20","author":"Gacci","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R28-20260605","first-page":"1029","article-title":"The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort.","volume":"25","author":"Gaines","year":"2014","journal-title":"Cancer Causes Control"},{"key":"R29-20260605","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.urolonc.2024.06.002","article-title":"A systematic review of family history, race\/ethnicity, and genetic risk on prostate cancer detection and outcomes: considerations in PSA-based screening.","volume":"43","author":"Graham","year":"2025","journal-title":"Urol Oncol"},{"key":"R30-20260605","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.amjmed.2013.08.012","article-title":"\u2018Race\u2019 and prostate cancer mortality in equal-access healthcare systems.","volume":"126","author":"Graham-Steed","year":"2013","journal-title":"Am J Med"},{"key":"R31-20260605","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.juro.2018.08.048","article-title":"Coffee, caffeine metabolism genotype, and disease progression in localized prostate cancer patients managed with active surveillance.","volume":"201","author":"Gregg","year":"2019","journal-title":"J Urol"},{"key":"R32-20260605","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/JU.0000000000001321","article-title":"The association of periprostatic fat and grade group progression in men with localized prostate cancer on active surveillance.","volume":"205","author":"Gregg","year":"2021","journal-title":"J Urol"},{"key":"R33-20260605","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/pros.24686","article-title":"A West African ancestry-associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening.","volume":"84","author":"Gu","year":"2024","journal-title":"Prostate"},{"key":"R34-20260605","first-page":"213","article-title":"Metabolic syndrome is associated with aggressive prostate cancer regardless of race.","volume":"34","author":"Guerrios-Rivera","year":"2023","journal-title":"Cancer Causes Control"},{"key":"R35-20260605","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/oby.2004.242","article-title":"Visceral fat accumulation as a risk factor for prostate cancer.","volume":"12","author":"von Hafe","year":"2004","journal-title":"Obes Res"},{"key":"R36-20260605","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41391-024-00870-8","article-title":"Body composition as a determinant of the therapeutic index with androgen signaling inhibition.","volume":"28","author":"Hahn","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R37-20260605","first-page":"431","article-title":"Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen.","volume":"31","author":"Harrison","year":"2020","journal-title":"Cancer Causes Control"},{"key":"R38-20260605","first-page":"25","article-title":"Dietary factors and risks for prostate cancer among blacks and whites in the United States.","volume":"8","author":"Hayes","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R39-20260605","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/cncr.11231","article-title":"Anatomic distribution of periprostatic adipose tissue: a mapping study of 100 radical prostatectomy specimens.","volume":"97","author":"Hong","year":"2003","journal-title":"Cancer"},{"key":"R40-20260605","doi-asserted-by":"crossref","first-page":"e106677","DOI":"10.1371\/journal.pone.0106677","article-title":"Obesity affects the biopsy-mediated detection of prostate cancer, particularly high-grade prostate cancer: a dose-response meta-analysis of 29,464 patients.","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"R41-20260605","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1467-789X.2009.00623.x","article-title":"Subcutaneous and visceral adipose tissue: structural and functional differences.","volume":"11","author":"Ibrahim","year":"2010","journal-title":"Obes Rev"},{"key":"R42-20260605","first-page":"909","article-title":"Body size and risk of prostate cancer in Jamaican men.","volume":"21","author":"Jackson","year":"2010","journal-title":"Cancer Causes Control"},{"key":"R43-20260605","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41585-023-00849-5","article-title":"The complex interplay of modifiable risk factors affecting prostate cancer disparities in African American men.","volume":"21","author":"Johnson","year":"2024","journal-title":"Nat Rev Urol"},{"key":"R44-20260605","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41591-019-0563-7","article-title":"Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease.","volume":"25","author":"Karlsson","year":"2019","journal-title":"Nat Med"},{"key":"R45-20260605","doi-asserted-by":"crossref","first-page":"643","DOI":"10.7150\/ijbs.8974","article-title":"Androgen receptor mutations and polymorphisms in African American prostate cancer.","volume":"10","author":"Koochekpour","year":"2014","journal-title":"Int J Biol Sci"},{"key":"R46-20260605","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/CIR.0000000000000182","article-title":"Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association.","volume":"131","author":"Kulik","year":"2015","journal-title":"Circulation"},{"key":"R47-20260605","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1158\/1055-9965.1646.13.10","article-title":"Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study.","volume":"13","author":"Laukkanen","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R49-20260605","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/pros.24281","article-title":"Metabolic syndrome and prostate cancer in Afro-Caribbean men.","volume":"82","author":"Lefebvre","year":"2022","journal-title":"Prostate"},{"key":"R50-20260605","doi-asserted-by":"crossref","first-page":"e2449855","DOI":"10.1001\/jamanetworkopen.2024.49855","article-title":"Allostatic load, educational attainment, and risk of cancer mortality among US men.","volume":"7","author":"Li","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R51-20260605","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1002\/cncr.34433","article-title":"Racial disparities in B lack men with prostate cancer: a literature review.","volume":"128","author":"Lillard","year":"2022","journal-title":"Cancer"},{"key":"R52-20260605","doi-asserted-by":"crossref","first-page":"55","DOI":"10.15698\/cst2021.05.248","article-title":"Cellular mechanisms linking cancers to obesity.","volume":"5","author":"Liu","year":"2021","journal-title":"Cell Stress"},{"key":"R53-20260605","first-page":"989","article-title":"Body size and composition and prostate cancer risk: systematic review and meta-regression analysis.","volume":"17","author":"MacInnis","year":"2006","journal-title":"Cancer Causes Control"},{"key":"R55-20260605","doi-asserted-by":"crossref","first-page":"106117","DOI":"10.1016\/j.psyneuen.2023.106117","article-title":"Towards a consensus definition of allostatic load: a multi-cohort, multi-system, multi-biomarker individual participant data (IPD) meta-analysis.","volume":"153","author":"McCrory","year":"2023","journal-title":"Psychoneuroendocrinology"},{"key":"R56-20260605","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/advances\/nmaa162","article-title":"Racial-Ethnic disparities in obesity and biological, behavioral, and sociocultural influences in the United States: a systematic review.","volume":"12","author":"Min","year":"2021","journal-title":"Adv Nutr"},{"key":"R57-20260605","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.5888\/pcd14.160287","article-title":"Metabolic syndrome prevalence by race\/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988-2012.","volume":"14","author":"Moore","year":"2017","journal-title":"Prev Chronic Dis"},{"key":"R58-20260605","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1158\/1055-9965.EPI-12-0071","article-title":"Central adiposity and prostate cancer in a black population.","volume":"21","author":"Nemesure","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R59-20260605","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.canlet.2021.09.021","article-title":"Help or hindrance: the obesity paradox in cancer treatment response.","volume":"522","author":"O\u2019Connell","year":"2021","journal-title":"Cancer Lett"},{"key":"R60-20260605","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.amjmed.2010.05.011","article-title":"Obesity and prostate cancer detection: insights from three national surveys.","volume":"123","author":"Parekh","year":"2010","journal-title":"Am J Med"},{"key":"R61-20260605","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1158\/1055-9965.EPI-18-0242","article-title":"Association of anthropometric measures with prostate cancer among African American Men in the NCI-Maryland prostate cancer case-control study.","volume":"27","author":"Pichardo","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R62-20260605","doi-asserted-by":"crossref","first-page":"e2251745","DOI":"10.1001\/jamanetworkopen.2022.51745","article-title":"Association of neighborhood deprivation with prostate cancer and immune markers in African American and European American men.","volume":"6","author":"Pichardo","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"R63-20260605","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1158\/1055-9965.EPI-08-0609","article-title":"Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition.","volume":"17","author":"Pischon","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R64-20260605","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.juro.2006.09.024","article-title":"Epidemiology and pathophysiology of prostate cancer in African-American men.","volume":"177","author":"Powell","year":"2007","journal-title":"J Urol"},{"key":"R65-20260605","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/advances\/nmab153","article-title":"Body composition and prostate cancer risk: a systematic review of observational studies.","volume":"13","author":"Purcell","year":"2022","journal-title":"Adv Nutr"},{"key":"R66-20260605","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/PPO.0000000000000688","article-title":"Prostate cancer, race, and health disparity: what we know.","volume":"29","author":"Roach","year":"2023","journal-title":"Cancer J"},{"key":"R67-20260605","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1158\/0008-5472.CAN-17-0284","article-title":"Proinflammatory CXCL12-CXCR4\/CXCR7 signaling axis drives myc-induced prostate cancer in obese mice.","volume":"77","author":"Saha","year":"2017","journal-title":"Cancer Res"},{"key":"R68-20260605","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2024.42.4_suppl.96","article-title":"Association of body-mass index (BMI) with age, PSA, and survival in metastatic prostate cancer.","volume":"42","author":"Schoen","year":"2024","journal-title":"J Clin Oncol"},{"key":"R69-20260605","doi-asserted-by":"crossref","first-page":"271.e1","DOI":"10.1016\/j.clgc.2020.08.003","article-title":"Causal diagram techniques for urologic oncology research.","volume":"19","author":"Shapiro","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"R70-20260605","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2288-8-70","article-title":"Reducing bias through directed acyclic graphs.","volume":"8","author":"Shrier","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"R71-20260605","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1002\/cncr.28127","article-title":"Ultraviolet index and racial differences in prostate cancer incidence and mortality.","volume":"119","author":"Taksler","year":"2013","journal-title":"Cancer"},{"key":"R72-20260605","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/aje\/kwj320","article-title":"The metabolic syndrome is associated with reduced risk of prostate cancer.","volume":"164","author":"Tande","year":"2006","journal-title":"Am J Epidemiol"},{"key":"R73-20260605","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41598-022-27269-6","article-title":"Assessment of metabolic syndrome predictors in relation to inflammation and visceral fat tissue in older adults.","volume":"13","author":"Tylutka","year":"2023","journal-title":"Sci Rep"},{"key":"R74-20260605","doi-asserted-by":"crossref","first-page":"e30191","DOI":"10.1097\/MD.0000000000030191","article-title":"The impact of body mass index on prostate cancer: an updated systematic review and meta-analysis.","volume":"101","author":"Tzenios","year":"2022","journal-title":"Medicine (Baltim)"},{"key":"R75-20260605","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1158\/1055-9965.EPI-14-0795","article-title":"Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study.","volume":"23","author":"Vidal","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R76-20260605","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1002\/cncr.32906","article-title":"Obesity, race, and long-term prostate cancer outcomes.","volume":"126","author":"Vidal","year":"2020","journal-title":"Cancer"},{"key":"R77-20260605","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/sj.bjc.6605077","article-title":"A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk.","volume":"100","author":"Wallstr\u00f6m","year":"2009","journal-title":"Br J Cancer"},{"key":"R78-20260605","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1210\/clinem\/dgae669","article-title":"Age difference in the connection between systemic inflammatory response and metabolic syndrome.","volume":"110","author":"Wei","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"R79-20260605","first-page":"4702","article-title":"Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP-PKA\/PI3K-Akt signaling pathway.","volume":"17","author":"Xu","year":"2018","journal-title":"Mol Med Rep"},{"key":"R80-20260605","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/JU.0000000000001428","article-title":"Obesity is associated with longer survival independent of sarcopenia and myosteatosis in metastatic and\/or castrate-resistant prostate cancer.","volume":"205","author":"Xu","year":"2021","journal-title":"J Urol"},{"key":"R81-20260605","doi-asserted-by":"crossref","first-page":"11674","DOI":"10.1038\/ncomms11674","article-title":"CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment.","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat Commun"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T09:01:09Z","timestamp":1780650069000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000992","relation":{},"ISSN":["0959-8278","1473-5709"],"issn-type":[{"value":"0959-8278","type":"print"},{"value":"1473-5709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"2025-09-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}